ERA-EDTA 2015: Immunosuppression for IgA Nephropathy
If and when to immunosuppress patients with the world’s commonest glomerular disease is a crucially important topic for Nephrologists. There is a large amount of [...]
immunosuppression
ATC 2013: Alemtuzumab Induction and Belatacept-Based Immunosuppression in Kidney Transplant Recipients
ATC abstract presentation: Alemtuzumab Induction and Belatacept-Based Immunosuppression in Renal Transplant Recipients: Peripheral Dynamics of T and B cell Populations with [...]
Patient Preference Versus Physician Preference of Immunosuppression
Immunosuppressive regimens are largely selected by physicians. Has anyone asked patients what they prefer? A unique and illustrative approach to understanding attitudes and [...]